Kållberg, CeciliaHudson, JemmaSalvesen Blix, HegeÅrdal, ChristineKlein, EiliLindbæk, MortenOutterson, KevinRøttingen, John-ArneLaxminarayan, Ramanan2021-06-032021-06-032021-05-18Kållberg, C, Hudson, J, Salvesen Blix, H, Årdal, C, Klein, E, Lindbæk, M, Outterson, K, Røttingen, J-A & Laxminarayan, R 2021, 'The effect of generic market entry on antibiotic prescriptions in the United States', Nature Communications, vol. 12, no. 1, 2937. https://doi.org/10.1038/s41467-021-23049-42041-1723Jisc: 5e0a541ec71743f88fedfce1ea4e8353pii: 10.1038/s41467-021-23049-4pmc: PMC8131704https://hdl.handle.net/2164/16623Acknowledgements C.K. and C.Å. were funded by the DRIVE-AB Consortium. DRIVE-AB is supported by the IMI Joint Undertaking under the DRIVE-AB grant agreement number 115618, the resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme and the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contribution. C.K. and C.Å. were partly supported by the Research Council of Norway through the Global Health and Vaccination Programme (GLOBVAC), project number 234608. K.O. is supported by NOA 06-IDSET160030 from the Biomedical Advanced Research and Development Authority (BARDA) under the Assistant Secretary for Preparedness and Response (ASPR) in the US Department of Health and Human Services, and the CARB-X award from the Wellcome Trust, but the views expressed herein are not necessarily those of CARB-X or any CARB-X funder. J.H. works for Health Services Research Unit, University of Aberdeen, and is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. R.L. was supported by 16IPA16092427 from the US Centers for Disease Control and Prevention. The funder provided support in the form of salaries for authors, according to the statement above, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.9816350engR MedicineSupplementary Informationhttps://doi.org/10.1038/s41467-021-23049-4Supplementary DataRThe effect of generic market entry on antibiotic prescriptions in the United StatesJournal article10.1038/s41467-021-23049-4121